| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.23 | 0.009 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.22 | 0.01 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.13 | 0.01 |